LivaNova and Verily in Research Agreement to Treat Depression

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 27, 2020 at 11:32 PM.

  1. #1 cafead, Feb 27, 2020 at 11:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via LivaNova has entered into a research partnership with Verily Life Sciences, an Alphabet company, to evaluate the effectiveness of Vagus Nerve Stimulation (VNS) therapy for Difficult to Treat Depression (DTD). The collaboration comes a few short months after London-based LivaNova ended its transcatheter mitral valve replacement (TMVR) program because of continued declines in revenue from its valve business.

    article source
     
    Quote

Reply to Thread